Skip to content
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Focal Sectors
Why EDBI
Why EDBI
Impact
Value Creation
Portfolio
News
Careers
Contact Us
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Focal Sectors
Why EDBI
Why EDBI
Impact
Value Creation
Portfolio
News
Careers
Contact Us
About Us
Corporate Profile
Senior Management
Board of Directors
Advisors and EDBI Connect
Core Values
Focal Sectors
Why EDBI
Why EDBI
Impact
Value Creation
Portfolio
News
Careers
Contact Us
Contact us
Inviragen & PharmaJet Receive $15.5M NIAID Contract to develop a needle-free Dengue Vaccine
7 October 2010
Inviragen and PharmaJet Receive $15.5 Million NIAID Contract to Develop a Needle-free Dengue Vaccine